Drug trial for kidney disease withdrawn before starting

NCT ID NCT06598631

Terminated Disease control Sponsor: Eli Lilly and Company Source: ClinicalTrials.gov ↗

Summary

This study aimed to test whether a new drug called volenrelaxin could help slow kidney damage in adults with chronic kidney disease. Participants would have received either the drug or a placebo for about 24 weeks while continuing their standard medications. The main goal was to see if the drug could reduce the amount of protein leaking into the urine, a key sign of kidney damage. However, the trial was withdrawn before any participants were enrolled.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Beijing Anzhen Hospital, Capital Medical University

Beijing, Beijing Municipality, 100029, China
CHUAC-Complejo Hospitalario Universitario A Coruña

A Coruña, A Coruña [La Coruña], 15006, Spain
Diabetes and Metabolism Associates, APMC

Metairie, Louisiana, 70006, United States
Eastern Nephrology Associates

Jacksonville, North Carolina, 28546, United States
Eastern Nephrology Associates - Greenville

Greenville, North Carolina, 27834, United States
Eastern Nephrology Associates - Wilmington

Wilmington, North Carolina, 28401, United States
Eastern Nephrology Associates- Kinston Office

Kinston, North Carolina, 28504, United States
Eastern Nephrology Associates- New Bern Office

New Bern, North Carolina, 28562, United States
Elite Clinical Research Center

Flint, Michigan, 48532, United States
Endocrine Associates

Houston, Texas, 77004, United States
Fiona Stanley Hospital

Murdoch, Western Australia, 6150, Australia
Hospital Clinico de Valencia

Valencia, Valenciana, Comunitat, 46010, Spain
Hospital Ribera Polusa

Lugo, Lugo [Lugo], 27004, Spain
Hospital Universitari Vall d'Hebron

Barcelona, Barcelona [Barcelona], 08035, Spain
Hospital Universitario Puerta de Hierro Majadahonda

Majadahonda, Madrid, Comunidad de, 28222, Spain
Hospital Universitario Virgen de la Victoria

Málaga, Andalusia, 29010, Spain
Liverpool Hospital

Liverpool, New South Wales, 2170, Australia
Lucas Research, Inc.

Morehead City, North Carolina, 28557, United States
Nephrology Associates of Northern Illinois and Indiana (NANI) - Fort Wayne

Fort Wayne, Indiana, 46804, United States
Nephrology Associates of Northern Illinois and Indiana (NANI) - Hinsdale

Hinsdale, Illinois, 60521, United States
Nephrology Associates of Northern Illinois and Indiana (NANI) - Huntley

Huntley, Illinois, 60142, United States
Nephrology Associates of Northern Illinois and Indiana - IKS - Indianapolis South

Indianapolis, Indiana, 46227, United States
Niigata University Medical & Dental Hospital

Niigata, 951-8520, Japan
Ningbo 2nd Hospital

Ningbo, Zhejiang, 315000, China
Okayama University Hospital

Okayama, 700-8558, Japan
Peking University First Hospital

Beijing, Beijing Municipality, 100034, China
Permian Research Foundation

Odessa, Texas, 79761, United States
Rancho Research Institute

Downey, California, 90242, United States
Renal Research - Gosford

Gosford, New South Wales, 2250, Australia
Southwest Nephrology Associates

Evergreen Park, Illinois, 60805, United States
Taian City Central Hospital

Taian, Shandong, 271000, China
Takai Internal Medicine Clinic

Kamakura-shi, Kanagawa, 247-0056, Japan
The Royal Melbourne Hospital

Parkville, Victoria, 3050, Australia
The first affiliated hospital of Ningbo university

Ningbo, Zhejiang, 315010, China
Yantai Yuhuangding Hospital

Yantai, Shandong, 264099, China

Conditions

Explore the condition pages connected to this study.

CHRONIC KIDNEY DISEASE